Pacira BioSciences, Inc. (PCRX): Price and Financial Metrics

Pacira BioSciences, Inc. (PCRX): $26.65

0.12 (-0.45%)

POWR Rating

Component Grades








Add PCRX to Watchlist
Sign Up

PCRX Price/Volume Stats

Current price $26.65 52-week high $48.60
Prev. close $26.77 52-week low $25.76
Day low $26.53 Volume 25,619
Day high $26.84 Avg. volume 490,301
50-day MA $29.06 Dividend yield N/A
200-day MA $31.68 Market Cap 1.24B

PCRX Stock Price Chart Interactive Chart >

Pacira BioSciences, Inc. (PCRX) Company Bio

Pacira Pharmaceuticals develops, commercializes, and manufactures proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. The company was founded in 2006 and is based in Parsippany, New Jersey.

PCRX Latest News Stream

Event/Time News Detail
Loading, please wait...

PCRX Latest Social Stream

Loading social stream, please wait...

View Full PCRX Social Stream

Latest PCRX News From Around the Web

Below are the latest news stories about PACIRA BIOSCIENCES INC that investors may wish to consider to help them evaluate PCRX as an investment opportunity.

Pacira Appoints Frank D. Lee as Chief Executive Officer

-- Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and Commercialization -- -- Paul J. Hastings Named Chair of the Board -- -- Dave Stack to Remain in Advisory Role through August 2025 -- TAMPA, Fla., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that its Board of Directors (th

Yahoo | December 21, 2023

Hedge Funds are Betting on These 14 Sliding Stocks

In this article, we will take a look at the hedge funds that are betting on these 14 sliding stocks. To see more such companies, go directly to Hedge Funds are Betting on These 5 Sliding Stocks. Stocks jumped on December 6 after the release of yet another welcome data point for the Federal Reserve, […]

Yahoo | December 6, 2023

Pacira (PCRX) Gets FDA Nod for Exparel's Label Expansion

The FDA approves Pacira's (PCRX) supplemental new drug application to expand the label of Exparel to include both sciatic and femoral nerve blocks.

Yahoo | November 13, 2023

Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications

— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor canal block and sciatic nerve block in the popliteal fossa will significantly extend reach within more than 3 million lower extremity procedures — TAMPA, Fla., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to non-opioid pain managemen

Yahoo | November 10, 2023

Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November

TAMPA, Fla., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences: Jefferies London Healthcare Conference on Tuesday, November 14th at 11:00AM GMT (6:00AM ET).35th Annual Piper Sandler Healthcare Conference on Tuesday, November 28th at 2:00PM ET. Live audio of the events can be accessed by visiting the “Events” page of the company’s website at investor.pacira.

Yahoo | November 7, 2023

Read More 'PCRX' Stories Here

PCRX Price Returns

1-mo -9.57%
3-mo -16.30%
6-mo -6.52%
1-year -41.30%
3-year -58.04%
5-year -27.60%
YTD -21.01%
2023 -12.61%
2022 -35.83%
2021 0.55%
2020 32.10%
2019 5.30%

Continue Researching PCRX

Want to see what other sources are saying about Pacira BioSciences Inc's financials and stock price? Try the links below:

Pacira BioSciences Inc (PCRX) Stock Price | Nasdaq
Pacira BioSciences Inc (PCRX) Stock Quote, History and News - Yahoo Finance
Pacira BioSciences Inc (PCRX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!